FDA Inspection
David C. Larsen, MDDavid C. Larsen, MD – FDA Inspection, Oct 22, 2008
Record Details
This FDA Inspection record concerns David C. Larsen, MD, with an inspection on October 22, 2008, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- David C. Larsen, MD
- Inspection Date
- October 22, 2008
- Product Type
- Drugs
View Company Profile
ID · d41f7d5a-3779-4f4b-9cda-89f4e77c99de
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 546031
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of David C. Larsen, MD
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 7, 2016 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for David C. Larsen, MD
- FDA Inspection 1080441 - 2019-02-05
- FDA Inspection 982036 - 2016-06-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.